Polymedics Innovations

PolyMedics Innovations (PMI) is a privately held medical device manufacturer based in Kirchheim unter Teck, Germany, with a U.S. subsidiary in Woodstock, Georgia. Founded in 2001, PMI specializes in innovative biomaterials and synthetic skin replacement technologies for acute and chronic wound treatment, particularly for burns and abrasions. The company's proprietary Engineered Polylactide Technology (SUPRA EPT™) produces non-biological, fully biodegradable synthetic skin substitutes that are reproducible, standardized, and completely metabolize to water and carbon dioxide. PMI's flagship product, SUPRATHEL®, has successfully treated over 250,000 patients globally across more than 40 countries. The product portfolio includes SUPRA SDRM®, a biodegradable matrix for chronic wounds, and SUPRA NET®, added in 2024. PMI's products are clinically proven to accelerate healing, reduce pain, and improve patient outcomes while minimizing infection risk. The company has achieved over 350% organic growth in the past five years and maintains strong partnerships in research and development to advance wound care solutions.